This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Rebel, H. Articles by Terleth, C. Search for Related Content PubMed PubMed Citation Articles by Rebel, H. Articles by Terleth, C.

Suppression of UV Carcinogenesis by Difluoromethylornithine in Nucleotide Excision Repair-deficient Xpa Knockout Mice¹

Department of Dermatology, Leiden University Medical Center, Sylvius Laboratory, 2300 RA, Leiden [H. R., F. R. d. G.]; National Institute of Public Health and the Environment, Laboratory of Health Effects Research [H. v. S.], Laboratory of Pathology and Immunology [R. B. B.], 3720 BA Bilthoven; and the Department of Radiation Genetics and Chemical Mutagenesis, Sylvius Laboratory, Leiden University Medical Center, 2300 RA, Leiden, [C. T., R. S.] The Netherlands

Xeroderma pigmentosum (XP) patients are deficient in nucleotide excision repair (NER) because of mutations in one of the genes coding for NER enzymes. This results predominantly in high frequency of UV-induced skin tumors at an early age; the most severe phenotype is found in patients of complementation group A (XPA). However, in a subset of these XPA patients no skin tumors appear, even at advanced age. Fibroblasts of this subset of patients are not capable of raising UV-induced enhanced reactivation (ER) of viruses and up-regulation of ornithine decarboxylase (ODC). We hypothesized that prevention of ODC induction would protect NER-deficient patients from cancer.

To simulate the situation in XPA patients, we used a hairless Xpa knockout mouse model and down-regulated the ODC activity by difluoromethylornithine (DFMO) administered in the drinking water. The DFMO treatment significantly suppressed UV-induced carcinogenesis. In a crossover study, we additionally found that discontinuation of the DFMO treatment resulted in a rapid appearance of skin tumors, up to levels found in mice not treated with DFMO. Late-stage DFMO treatment significantly reduced the number of carcinomas by a factor of 2–3, and it appeared to select for carcinomas with high ODC activity. These results indicate that DFMO suppresses the outgrowth but not the initiation of UV-induced tumors. The DFMO treatment reduced the tumor load but did not offer the Xpa knockout mice full protection against UV carcinogenesis.

This article has been cited by other articles:

				A. van Schanke, G. M.C.A.L. van Venrooij, M. J. Jongsma, H. A. Banus, L. H.F. Mullenders, H. J. van Kranen, and F. R. de Gruijl Induction of Nevi and Skin Tumors in Ink4a/Arf Xpa Knockout Mice by Neonatal, Intermittent, or Chronic UVB Exposures. Cancer Res., March 1, 2006; 66(5): 2608 - 2615. [Abstract] [Full Text] [PDF]

				D. L. Wheeler, K. J. Ness, T. D. Oberley, and A. K. Verma Inhibition of the Development of Metastatic Squamous Cell Carcinoma in Protein Kinase C {epsilon} Transgenic Mice by {alpha}-Difluoromethylornithine Accompanied by Marked Hair Follicle Degeneration and Hair Loss Cancer Res., June 15, 2003; 63(12): 3037 - 3042. [Abstract] [Full Text] [PDF]